The methylation levels of the SEPT9 gene were significantly (p = 0.009) higher in CRC patients (1.865 ± 2.053) than in healthy donors (0.0133 ± 2.591) (Fig. 2-B, D) with a p-value of 0.009. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.